Saturday, December 6, 2025

Tesla Stock Dips 6% as BYD Races Ahead with $7,000 Robotaxis

Tesla's stock fell 6% after BYD's announcement of affordable autonomous vehicles, intensifying competition in the EV market.

HLB Therapeutics CEO: New Eye Drop Could Disrupt the Market for Rare Corneal Disease

HLB Therapeutics CEO anticipates RGN-259 could surpass Oxervate within 3 years as a simpler, cost-effective NK treatment.

Tag: Gaza

No posts to display

Top News

- Our Sponsors Ad -

Follow us